peroxynitrous acid has been researched along with copper bis(3,5-diisopropylsalicylate) in 1 studies
Studies (peroxynitrous acid) | Trials (peroxynitrous acid) | Recent Studies (post-2010) (peroxynitrous acid) | Studies (copper bis(3,5-diisopropylsalicylate)) | Trials (copper bis(3,5-diisopropylsalicylate)) | Recent Studies (post-2010) (copper bis(3,5-diisopropylsalicylate)) |
---|---|---|---|---|---|
3,303 | 21 | 1,230 | 62 | 0 | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boileau, C; Dumond, H; Jouzeau, JY; Martel-Pelletier, J; Netter, P; Pacquelet, S; Pelletier, JP; Presle, N; Terlain, B | 1 |
1 other study(ies) available for peroxynitrous acid and copper bis(3,5-diisopropylsalicylate)
Article | Year |
---|---|
Interleukin 17, a nitric oxide-producing cytokine with a peroxynitrite-independent inhibitory effect on proteoglycan synthesis.
Topics: Animals; Cartilage, Articular; Cells, Cultured; Chondrocytes; Dose-Response Relationship, Drug; Drug Combinations; Hindlimb; Injections, Intra-Articular; Interleukin-1; Interleukin-17; Joints; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peroxynitrous Acid; Proteoglycans; Rats; Rats, Wistar; Recombinant Proteins; RNA, Messenger; Salicylates | 2002 |